Company Filing History:
Years Active: 2013-2014
Title: TsungYu Hsiao: Innovator in Pharmaceutical Chemistry
Introduction
TsungYu Hsiao is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of cabazitaxel, a drug used in cancer treatment. With a total of 3 patents to his name, Hsiao's work has had a notable impact on the industry.
Latest Patents
Hsiao's latest patents include innovative crystalline forms of cabazitaxel. The present invention provides crystalline forms, including an anhydrate form, of cabazitaxel and processes for the preparation of these forms, designated as Forms C1, C2, C3, C4, C5, C6, C7, C8, C8b, C9, and C9p. Another significant patent relates to the process for cabazitaxel and intermediates thereof. This invention focuses on processes for making cabazitaxel, cabazitaxel analogues, and intermediates, providing novel compounds useful in the synthesis of cabazitaxel.
Career Highlights
Hsiao is currently employed at Scinopharm Taiwan, Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficacy and safety of cancer treatments.
Collaborations
Hsiao has collaborated with notable colleagues, including Julian Paul Henschke and MengFen Ho. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
TsungYu Hsiao is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patents and collaborations reflect his commitment to advancing cancer treatment. His work continues to inspire future innovations in the field.